Avecho Biotechnology
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Industry Lists
Public Companies - non WAAvecho Biotechnology Limited (AVE , formerly Phosphagenics Limited) develops and commercialises Human and Animal Health products using its proprietary drug delivery system called TPM (Targeted Penetration Matrix).
Contact Details
Unit A8, Hallmarc Business Park, 2A Westall Rd, CLAYTON VIC 3168
03 9002 5000
Lists and Charts
Share Price
Closing price for the last 90 trading days
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Avecho Biotechnology | $1.6m |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1701st | Avecho Biotechnology | -67% | -6% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Company Activity
 | NEW ROLE: Roksan Libinaki, General Manager | 24 Nov 2020 |
| NEW ROLE: Anna Legg, Former Chief Financial Officer/Secretary | 24 Nov 2020 |
| NEW ROLE: Alex Stojanovic, Vice President - Business Development & Commercial Operations | 24 Nov 2020 |
| NEW ROLE: Matt McNamara, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: Melanie Leydin, Chief Financial Officer, Company Secretary | 03 Nov 2020 |
| NEW ROLE: Paul Gavin, Chief Executive Officer | 03 Nov 2020 |
| NEW ROLE: Greg Collier, Non-Executive Chairman, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: David Segal, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: Ross Murdoch, Non-Executive Director | 03 Nov 2020 |
